Literature DB >> 30416857

Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1/DDX3 axis.

Song You1,2, Fuqiang Wang3,1, Qing Hu4, Pengtao Li3,1, Changmao Zhang1,2, Yaqi Yu1, Yi Zhang1, Qiu Li1, Qing Bao1, Pingguo Liu3,1, Jie Li3,1.   

Abstract

YEATS domain containing 4 (YEATS4) is usually amplified and functions as an oncogene in several malignancies, such as colorectum, ovarian, breast and lung. However, the biological role of YEATS4 in hepatocellular carcinoma (HCC) has not yet been discussed. Herein, we found that YEATS4 was significantly upregulated in HCC compared to para-cancerous tissues, and was associated with poor prognosis, large tumor size, poor differentiation and distant metastasis. In addition, YEATS4 promoted HCC cell proliferation and colony formation by binding to and increasing the transcriptional activity of the TCEA1 promoter. Concurrently, upregulation of TCEA1 increased the stability of the DDX3 protein, a member of the DEAD box RNA helicase family, and augmented the proliferative and colony forming ability of HCC cells. Furthermore, YEATS4 accelerated tumor growth in vivo in a xenograft HCC model. Taken together, our study provides evidence for the first time on the potential role of the YEATS4/TCEA1/DDX3 axis in regulating HCC progression, and presents YEATS4 as a promising therapeutic target and prognosis maker for HCC.

Entities:  

Keywords:  DDX3; TCEA1; YEATS4; hepatic carcinoma; prognosis; proliferation

Year:  2018        PMID: 30416857      PMCID: PMC6220140     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  37 in total

1.  Knockdown of YEATS4 inhibits colorectal cancer cell proliferation and induces apoptosis.

Authors:  Kun Tao; Jing Yang; Yuemei Hu; Anmei Deng
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  Gene structure and chromosome mapping of mouse transcription elongation factor S-II (Tcea1).

Authors:  T Ito; M F Seldin; M M Taketo; T Kubo; S Natori
Journal:  Gene       Date:  2000-02-22       Impact factor: 3.688

3.  Twelve amplified and expressed genes localized in a single domain in glioma.

Authors:  U Fischer; P Meltzer; E Meese
Journal:  Hum Genet       Date:  1996-11       Impact factor: 4.132

4.  DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.

Authors:  H-H Chen; H-I Yu; W-C Cho; W-Y Tarn
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

5.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

6.  DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.

Authors:  D-W Wu; M-C Lee; J Wang; C-Y Chen; Y-W Cheng; H Lee
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

7.  Global response to the burden of cancer: the WHO approach.

Authors:  Andreas Ullrich; Anthony Miller
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

Review 8.  Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases.

Authors:  Ana Lúcia Leitão; Marina C Costa; Francisco J Enguita
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

9.  DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.

Authors:  Hao-Kang Li; Ru-Tsun Mai; Hsien-Da Huang; Chih-Hung Chou; Yi-An Chang; Yao-Wen Chang; Li-Ru You; Chun-Ming Chen; Yan-Hwa Wu Lee
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

Review 10.  DDX3, a potential target for cancer treatment.

Authors:  Guus Martinus Bol; Min Xie; Venu Raman
Journal:  Mol Cancer       Date:  2015-11-05       Impact factor: 27.401

View more
  5 in total

1.  Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.

Authors:  Xiaomin Ni; David Heidenreich; Thomas Christott; James Bennett; Moses Moustakim; Paul E Brennan; Oleg Fedorov; Stefan Knapp; Apirat Chaikuad
Journal:  ACS Med Chem Lett       Date:  2019-11-25       Impact factor: 4.345

2.  Quantitative proteomics of HFD-induced fatty liver uncovers novel transcription factors of lipid metabolism.

Authors:  Shang Zhi; Zhang Congcong; Gao Zhiling; Qian Yihan; Xin Yijing; Liu Guanjie; Wang Fang; Sun Xuehua; Li Hongjie; Kong Xiaoni; Gao Yueqiu
Journal:  Int J Biol Sci       Date:  2022-05-01       Impact factor: 10.750

3.  MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.

Authors:  Jie Ni; Li Chen; Li Ling; Mengfei Wu; Qiongzhen Ren; Weipei Zhu
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

4.  Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.

Authors:  Tingjie Wang; Ningxin Dang; Guangbo Tang; Zihang Li; Xiujuan Li; Bingyin Shi; Zhong Xu; Lei Li; Xiaofei Yang; Chuanrui Xu; Kai Ye
Journal:  Mol Oncol       Date:  2022-03-01       Impact factor: 7.449

Review 5.  DDX3X Multifunctionally Modulates Tumor Progression and Serves as a Prognostic Indicator to Predict Cancer Outcomes.

Authors:  Tsung-Chieh Lin
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.